Replies to post #663317 on NorthWest Biotherapeutics Inc (NWBO)

[CaptainObvious]

I see you've taken the glass 9/10 empty viewpoint.

[StonkMaster]

I'd be ok with $4-5 post approval in UK (more with NICE coverage + EDEN).

[dennisdave]

Current OS, back of the napkin has me at $3.84 valuation based on UK approval (for GBM and rGBM)

After the stock price rises sub $1 for whatever reason I dont see any retail buying NWBO stock anymore, why should they if they had the chance to buy the stock sub 75 cents for many many months? As long as we are on the OTC I dont see the SP get above $1.5 for what ever reason. I fully agree with Viking that we should have a reverse split 1:10 after UK approval to then uplist so institutions can buy in. There is no other way

[FeMike]

Woof, here's one I absolutely whiffed on. I gotta take the 'L' on this guess.

what is your sp expectation post uk approval mike

Current OS, back of the napkin has me at $3.84 valuation based on UK approval (for GBM and rGBM)

Given how historically undervalued this stock is (retail gives the pipeline no consideration), I'd say that's reasonable with no other news.